WntResearch has announced the appointment of Per Norlén as its new CEO. He replaces Pernilla Sandwall who has been CEO of the company since 2022. Norlén is essentially a doctor at Lund University and has worked for 20 years in various leading positions in the pharmaceutical industry and the biotechnology sector.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.3 SEK | +1.48% | -0.58% | +11.96% |
05-03 | WntResearch AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-29 | WntResearch AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+11.96% | 8.45M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.44% | 13.39B | |
+27.89% | 11.1B |
- Stock Market
- Equities
- WNT Stock
- News WntResearch AB
- WntResearch Announces CEO Changes